Ganfort eye drops

Ganfort is a combination eye drop solution containing bimatoprost (0.3 mg/ml) and timolol (5 mg/ml), used to treat high intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The product is manufactured by Allergan, Inc., a U.S.-based pharmaceutical company. In 2023, Allergan was acquired by AbbVie Inc., a global biopharmaceutical company headquartered in the United States. Ganfort is produced in multiple countries, including the United States and Italy, to meet global demand. The product is available in various packaging formats, including single-dose containers and multi-dose bottles, depending on the market. The packaging typically features the Ganfort brand name, the active ingredients, and usage instructions. As of January 2026, AbbVie Inc. remains the ultimate owner of the Ganfort brand.